Posters at Congress

Congratulations to poster winners -


Genomics - Adewale Oke
Education, training and management - Wendy Leversuch
Transfusion - Nicola Swarbrick 


Cellular Pathology - Jeyrroy Gabriel
Cytopathology - Monika Bhardwaj
Medical Microbiology - Simon Munro
Virology - James Burton


Clinical Chemistry - Nicola McDonagh
Immunology - Emma Braybrook
Point of Care Testing - Festus Ituah
Quality Management - Ayesha Shakhawat

Tuesday posters
Genomics and Molecular Pathology
Presenter Company Title Board no.
Abubacarr Camara New Cross Hospital, Wolverhampton RT-LAMP in the screening of NHS staff for COVID –19 1
Adewale Oke Ajayi Crowther University, Nigeria Phylogeny of Mycobacterium ulcerans strains in Nigeria - A Preliminary Study 2
Mark Litchfield Fleet Street Clinic SARS-CoV-2 rt-PCR: Performance comparison between NeuMoDx and Thermofisher TaqPath assays 3
Helen Lewis Haemophilia Haemostasis and Thrombosis Department, Hampshire Hospitals NHS Foundation Trust A rare and unexpected case of FXIII deficiency 4
Presenter Company Title Board no.
Beth Brannan Diagnostic Haemostasis, Viapath Analytics, St Thomas’ Hospital Time to FRET? Verification of the Technoflour FXIII Activity Assay  5
Sanjiv Tugnait Viapath Analytics, St. Thomas’ Hospital Platelet ATP release measurement. Whole blood or platelet rich plasma? 6
Andrea Teuchert UK NEQAS Haematology, Watford General Hospital Developing EQA for Automated Cell Imaging Systems 7
Elaine Bromidge Viapath Analytics, Haemostasis, St Thomas' Hospital EQA for rarely performed specialised haemostasis assays- the Viapath challenges 9
Eleanor Foxton Viapath Analytics, Haemostasis, St Thomas' Hospital Standardisation of the FVIII Nijmegen Bethesda – a dream or reality? 10
Lynda Bowes Royal Liverpool and Broadgreen University Hospitals NHS Trust An assessment of the utility of CD15, CD16 and CD56 in evaluating dysplasia severity in myelodysplastic syndromes 11
Jane Needham Hampshire Hospitals NHS Trust Diagnostic repertoire for investigation of suspected Platelet Function Disorders 12
Nadia Couvert Jersey General Hospital COVID-19: Haematological changes and associated mortality risk in hospitalised patients 13
Samantha Papp Black Country Pathology Services, Newcross Hospital The Knowledge and Understanding of Haemoglobinopathies in the West Midlands 14
Stephanie Shail Newcastle Hospitals NHS Foundation Trust Review of New Plasma Cell Flow Cytometry 15
Yvonne Chibanda   Hepcidin levels in pregnant women on iron replacement therapy 16
Transfusion Science
Presenter Company Title Board no.
Anas Nasir Viapath Maintaining transfusion education for biomedical scientists during the COVID-19 pandemic 17
Samantha Connelly Viapath Allo-immunisation and the implication for future blood requirements: Case Review 18
Matthew Hazell NHS Blood and Transplant Personalised Obstetric Transfusion Strategy for Rare Red Blood Cell Antigens 19
Shruthi Narayan SHOT Are we asking the right questions when things go wrong? 20
Nicola Swarbrick SHOT System overload: A SHOT case study of alert fatigue 21
Education, Training and Laboratory Management
Presenter Company Title Board no.
Cherie Millar Ulster University Embedding scientific communication and digital capabilities in the Biomedical Science curricula 22
Cherie Millar Ulster University Using digital tools to encourage teamwork and establish distance learning communities 23
Hannah McGregor UK Health Security Agency Capturing competence: evaluating positive safety culture by improving laboratory training 24
Ian Davies Staffordshire University Developing Potential - Evaluation of Nationwide Training Programme to Support SARS-CoV-2 Testing 25
Ian Davies Staffordshire University Degree Apprenticeships - Four Years On  26
Kathryn Dudley University of Wolverhampton How important are patient outcomes for Biomedical Scientists? 27
Sarah Pitt University of Brighton Testing Times: Feelings of Institute of Biomedical Science members during the COVID-19 pandemic   28
Victoria Heath Great Ormond Street Hospital for Children NHS Foundation Trust Work experience during COVID-19: Student perspectives of STEM careers engagement 29
Victoria Moyse HCA Healthcare UK Investigating current approaches to post-registration training and progression for Biomedical Scientists 30
Wendy Leversuch Health Services Laboratories An Investigation into the use of online training videos in support of laboratory bench training 31


Wednesday posters
Presenter Company Title Board no.
James Burton Great Ormond Street Hospital for Children NHS Foundation Trust Coincidental detection of Bocavirus during rapid COVID-19 screening from a specialist paediatric population: a retrospective observational study 1
Samir Dervisevic Norfolk and Norwich University Hospitals NHS Foundation Trust Evaluating the performance of the NeuMoDx™ EBV Quant Assay in comparison to the artus® EBV QS-RGQ Kit for use in a busy laboratory 2
Daniel Baird Victoria Hospital, Kirkcaldy Evaluating the use of Copan eNAT® and E&O VPSS transport media types for SARS-CoV-2 testing on the NeuMoDx random access RT-PCR platform 4
Muhammad Shahid Public Health England The development and evaluation of a multiplex real time PCR assay for the diagnosis of Acanthamoeba and Herpes Simplex Keratitis 5
Helen Jones   Validation of the Sigma MM™ swabs for the detection of SARS-CoV-2 6
Khamran Khan   SARS-CoV-2 stability testing using the Sigma MM™ deactivating media 7
Anuja Rasarathnam Bedfordshire Hospitals NHS Foundation Trust Haematological and biochemical pathology markers for predictive model for ITU admission and death from Covid19 – a retrospective study in Bedford Hospital NHS Trust 8
Medical Microbiology
Presenter Company Title Board no.
Jack McKoen Manchester Medical Microbiology Partnership, Manchester University NHS Foundation Trust The Outbreak Module:  A partnership between Biomedical Scientists and Universities 10
Mohammed Islam Public Health England Development of an External Quality Assessment Scheme for the Detection of Carbapenemase Producing Organisms 11
Laura Jones Royal Devon and Exeter NHS Foundation Trust The Exeter Experience—Introducing MicroScan WalkAway 96 and autoSCAN-4 12
Sophie Jones Public Health Wales Microbiology Cardiff The prevalence of Mycoplasma genitalium and Trichomonas vaginalis in Europe 13
Victoria Heath  Great Ormond Street Hospital for Children NHS Foundation Trust Does my hand trump yours? Microbial contamination levels of playing cards 14
Gemma Martin University of Brighton The impact of the COVID-19 pandemic on hand hygiene behaviours  15
Sanjiv Rughooputh UK NEQAS For Microbiology, Public Health England UK NEQAS for Microbiology new EQA scheme: SARS-CoV-2 antigen detection 16
Alan Williams HSL Pathology Impact of an automated plate reader for MRSA & Urine culture plates 17
Lynne Lawrance University of the West of England Uncertainty of Measurement in Antimicrobial Susceptibility Testing of Moraxella catarrhalis 18
Simon Munro Basingstoke and North Hampshire Hospital Reducing prophylactic antibiotic use for intradetrusor injections of Botulinum toxin 19
Tawfiq Juraybi Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University Screening Natural Products for Antibacterial Activity Against Acinetobacter baumannii 20
Samuel Boadi UK NEQAS Parasitology, National Infection Services, Public Health England An innovative approach to teaching parasite microscopy online 21
Cellular Pathology
Presenter Company Title Board no.
Alix Costello Whiston Hospital, St. Helens and Knowsley NHS Trust Evaluation of colorectal biopsy processing on adequacy for molecular testing 22
Elsa Santos CRUK Cambridge Institute, University of Cambridge, Li Ka Shing Centre Comparison of fluorescent imaging systems for increasing multiplex capabilities 23
Jemma Shead HSL Advanced Diagnostics FISH reporting in a referral laboratory: The benefits of BioView 24
Jeyrroy Gabriel Viapath, An NHS Partnership with Synlab Evaluation of haematoxylin subtypes for the optimal microscopic interpretation of cutaneous malignancies 25
Karolina Wojcik Viapath, An NHS Partnership with Synlab The significance and evaluation of the expression of PRAME in melanocytic lesions 26
Márcia Mateus Dias Queen Victoria Hospital NHS Trust, East Grinstead Comparison of Histopathology turnaround times for mandibulectomies, glossectomies and toutine tongue biopsies 27
Presenter Company Title Board no.
Monika Bhardwaj The Royal Wolverhampton NHS Trust, New Cross Hospital High-risk Human Papillomavirus (hrHPV) genotypes and Cervical Cancer 29
Jane Girgis New Cross Hospital, The Royal Wolverhampton NHS Trust Outcome audit of borderline endocervical cells in ThinPrep cervical samples 30


Thursday posters
Quality Management
Presenter Company Title Board no.
Rizalea Echaluse Health Services Laboratories Measuring The Impact of Digital Dashboards on IQC/Maintenance Monitoring 1
Francis Yongblah Great Ormond Street for Children NHS Foundation Trust Utilising online learning tools to reduce pre-analytic errors 2
Rebecca Ives   Reliability of HIV Viral Load Testing from Primary Tubes and Uncertainty of Measurement of HIV Quantitative PCR Assay 3
Ayesha Shakhawat    An audit -the utilization of group O D negative blood  4
Joy Osagie   A Retrospective, Randomised Audit on the Appropriate Use of Coagulation Tests in the Accident and Emergency Department at The Princess Alexandra Hospital NHS Trust 5
Point of Care Testing
Presenter Company Title Board no.
Jasminder Dhillon University Hospitals of Leicester NHS Trust Implementation of Rapid Point-of-Care SARS-Cov-2 Antigen Test in Emergency Pathway 6
Festus Ituah   RT-LAMP; A new method for detecting COVID-19 in patients’ saliva at the Royal Wolverhampton NHS Trust 7
Lee Peters  Morriston Hospital Evaluation of a POCT G6PD method 8
Clinical Chemistry
Presenter Company Title Board no.
Carolyn Piggott Bowel Cancer Screening Programme, Southern Hub Haemoglobin Stability in the OC-SENSOR faecal immunochemical test sampling bottle 9
Colin Stone King's College Hospital NHS Foundation Trust Delivering the DVLA CDT Testing Contract: statistical analysis of results 10
James Murphy Morriston Hospital, Swansea A verification of biotin interference in four Roche Immunoassays 11
Monica Muvindi Milton Keynes University Hospital Assay verification and the Adoption of Procalcitonin Guided Antibiotic Stewardship    12
Nicola McDonagh Royal Alexandra Hospital, Paisley Verification and Evaluation of the Siemens ELF™ Profile as a Liver Fibrosis Marker in Psoriasis Patients on Methotrexate 13
Sally Russell Bowel Cancer Screening Programme, Southern Hub Determination of detection capability parameters for the faecal immunochemical test 14
Shane O'Driscoll Bowel Cancer Screening Programme, Southern Hub Evaluation of a faecal calprotectin method using the OC-SENSOR PLEDIA 15
Kate Ottaway University of Brighton and University Hospitals Sussex NHS Foundation Trust Analytical interference of serum proteins with the Roche Elecsys Anti-SARS-CoV-2 immunoassay 16
Samuel Brown University of Brighton and University Hospitals Sussex NHS Foundation Trust Evaluating linearity in qualitative serological SARS-CoV-2 assays 17
Susan Ajo Manchester University NHS Foundation Trust MTBE and hexane liquid-liquid extraction of Aldosterone and LC-MS/MS analysis 18
Presenter Company Title Board no.
Catherine Sims Queen's Medical Centre, Nottingham University Hospitals NHS Trust Verification of a new assay to detect Systemic Sclerosis antibodies 19
Helen Lock King's College Hospital NHS Foundation Trust Measurement of CXCL10 in the Management of COVID-19 20
Melese Tedla Health Services Laboratory, Immunology Comparison of Autoimmune Diagnostic Diabetic Markers Type-1 Diabetes Miletus 21
Vibesan Illampooranan   Whether KIR genotyping would be beneficial for tissue typing laboratories 22
Emma Braybrook   The impact of SARS-CoV-2 B.1.1.7 on circulating biomarkers in hospitalised patients during the second wave of the COVID-19 pandemic in the UK 23